Related Experiment Video
Updated: Jun 3, 2026
08:27
A New Hybrid Quantitative Evaluation Model for Axillary Junctional Hemorrhage in Swine
Published on: December 6, 2024
[Discussion on collateral puncture therapy in Japan]
Ken Takagi1, Zhong-Zheng Li, Xi-Zhong Li
1Acupuncture Research Center, Tianjin University of TCM, Tianjin 300193, China.
Zhongguo Zhen Jiu = Chinese Acupuncture & Moxibustion
|March 30, 2011
Summary
Collateral puncture therapy in Japan evolved from Chinese origins, integrating Japanese acupuncture with European bloodletting techniques. Modern advancements by Kudo Kunsei and Tetuo Asami have led to its acceptance in Japan's healthcare system.
Area of Science:
- Traditional East Asian Medicine
- Medical History
- Acupuncture and Moxibustion
Context:
- Explores the historical development and current standing of collateral puncture therapy in Japan.
- Highlights the unique synthesis of Chinese, Japanese, Portuguese, and Dutch medical traditions.
- Examines the influence of key figures like Kudo Kunsei and Tetuo Asami.
Purpose:
- To trace the history of collateral puncture therapy in Japan.
- To introduce its current status and characteristics.
- To analyze its integration into the Japanese healthcare system.
Summary:
- Collateral puncture therapy originated in China and was adapted in Japan, incorporating acupuncture knowledge with European bloodletting practices.
- Kudo Kunsei's work established modern standards, while Tetuo Asami's new theory further refined the practice.
- This therapy, with distinct Japanese characteristics, is increasingly recognized within Japan's medical community.
Impact:
- Provides a historical overview of a unique therapeutic modality.
- Documents the evolution and adaptation of traditional medicine.
- Suggests growing acceptance and integration of collateral puncture therapy in contemporary Japanese healthcare.
Related Concept Videos
01:16Clot Retraction and Fibrinolysis
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...